%20--%3e%3csvg%20width='63.297821mm'%20height='39.29665mm'%20viewBox='0%200%2063.297821%2039.29665'%20version='1.1'%20id='svg8765'%20inkscape:version='1.1%20(c4e8f9ed74,%202021-05-24)'%20sodipodi:docname='OBALogoSingle2.svg'%20xmlns:inkscape='http://www.inkscape.org/namespaces/inkscape'%20xmlns:sodipodi='http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:svg='http://www.w3.org/2000/svg'%3e%3csodipodi:namedview%20id='namedview8767'%20pagecolor='%23ffffff'%20bordercolor='%23666666'%20borderopacity='1.0'%20inkscape:pageshadow='2'%20inkscape:pageopacity='0.0'%20inkscape:pagecheckerboard='0'%20inkscape:document-units='mm'%20showgrid='false'%20fit-margin-top='0'%20fit-margin-left='0'%20fit-margin-right='0'%20fit-margin-bottom='0'%20inkscape:zoom='1.1759259'%20inkscape:cx='179.85827'%20inkscape:cy='102.04724'%20inkscape:window-width='1920'%20inkscape:window-height='972'%20inkscape:window-x='0'%20inkscape:window-y='27'%20inkscape:window-maximized='1'%20inkscape:current-layer='layer1'%20/%3e%3cdefs%20id='defs8762'%20/%3e%3cg%20inkscape:label='Layer%201'%20inkscape:groupmode='layer'%20id='layer1'%20transform='translate(-31.351095,-50.101677)'%3e%3cpath%20style='fill:none;stroke:%233584e4;stroke-width:3.965;stroke-linecap:square;stroke-linejoin:round;stroke-miterlimit:4;stroke-dasharray:none;stroke-opacity:1'%20d='m%2077.07508,77.78787%2014.84134,8.87817%20V%2052.83397%20L%2034.08359,86.5521%20V%2053.69366%20l%2015.27351,9.31107'%20id='path8388'%20sodipodi:nodetypes='cccccc'%20/%3e%3c/g%3e%3c/svg%3e)
#us stocks
Stock analysis posts tagged "us stocks" from Openbook.
Lam Research (LRCX) Fundamentals: Etch, Deposition and Service
A Lam Research stock analysis of the etch and deposition maker: fiscal 2026 results, its installed-base service business, and the risks to watch.
Breaking Down Netflix (NFLX) Shares: Subscriptions and Ad Breaks
A Netflix stock analysis of the streaming business: Q2 2026 revenue, margins, the advertising build-out, free cash flow and what to watch from here.
Moderna (MRNA) Stock Analysis: The Melanoma Data and the Numbers
A Moderna stock analysis after the 177 percent move: what the INTerpath-001 melanoma readout disclosed, Q2 2026 revenue and losses, and the cash runway.
A Closer Look at Palantir (PLTR) Shares: Defense and Enterprise
A Palantir stock analysis grounded in the Q2 2026 results: 93 percent revenue growth, the US government and commercial split, margins, cash and dilution.
Inside AbbVie (ABBV) Shares: Immunology, Neuroscience and Botox
This AbbVie stock analysis breaks down Q2 2026 results, the Skyrizi and Rinvoq franchises that replaced Humira, margins, the dividend and key risks.
GE Aerospace (GE) Fundamentals: Engines, Spares and Overhauls
A GE Aerospace stock analysis covering how the engine maker earns from spare parts and overhauls, its Q2 2026 results and raised guidance, and the backlog, margin mix and risks worth tracking.
How Home Depot (HD) Makes Its Money: Aisles and Job Sites
A Home Depot stock analysis of the business behind the orange aprons: 2,359 stores, the SRS and GMS distribution deals, and what Q1 fiscal 2026 showed.
Oracle (ORCL) Fundamentals: Databases, ERP and Cloud Capacity
An Oracle stock analysis grounded in fiscal 2026 results: $67.4bn revenue, a $638bn contracted backlog and $55.7bn of capex. What the numbers show and what to watch.
What Drives Procter and Gamble (PG) Shares: Laundry to Diapers
A Procter and Gamble (PG) stock analysis grounded in the fiscal 2026 results: organic sales, margins, the dividend record and the fiscal 2027 cost headwinds worth watching.
Inside Costco Wholesale (COST) Shares: Membership Fee Economics
Costco stock analysis: how membership fees, an 11% gross margin and steady warehouse openings shape what COST actually reports each quarter.